USA: Researchers have found in a new study that patients with idiopathic intracranial hypertension (IIH) treated with ...

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki's ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best oversold NASDAQ stocks to buy now. On June 30, H.C. Wainwright ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...